high risk, refractory Neuroblastomas of the bone or bone marrow
high risk, refractory Neuroblastomas of the bone or bone marrow is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.
- Indicated drugs
What you can answer from here — as of October 04, 2026
1Indicated drugWith each drug's targets and mechanismListed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for high risk, refractory Neuroblastomas of the bone or bone marrow share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account